Jerusalem-based Enlivex reports promising results in treating small number of Covid-19 patients
01.10.20 | Reuters
This site uses cookies to ensure the best viewing experience for our readers.
Enlivex
4 stories about Enlivex
Enlivex Leveraged Coronavirus to Get Money out of Shareholders
26.02.20 | Uri Tal-Tene
CEO of Nasdaq-Listed Cell Immunotherapy Company Enlivex Steps Down
02.10.19 | Tzally Greenberg
Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million
28.03.19 | Lilach Baumer
Tag does not exist. Please try again.